Data + Perspectives: The Current and Future Role of Immune
Checkpoint Inhibitors and Other Novel Therapies in the Management
of Gynecologic Cancers — Interview with Dr Matulonis on the
following topics:
Perspective on the use of immune checkpoint inhibitor (ICI)
therapy for patients with ovarian cancer (00:00)
Incorporation of pembrolizumab and pembrolizumab/lenvatinib
into the management of endometrial cancer; optimal duration and
schedule of pembrolizumab therapy (5:33)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.